Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06539442

Versius Paediatrics Study

Prospective Clinical Study to Assess the Safety and Efficacy of Versius, in Urological Procedures in Paediatrics

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
CMR Surgical Ltd · Industry
Sex
All
Age
0 Years – 17 Years
Healthy volunteers
Not accepted

Summary

This is prospective, multi-phase, single arm, multi-centre, multi-surgeon feasibility clinical trial to provide proof of concept and clinical evidence regarding the safety and efficacy of Versius (robotic surgery medical device) in Urological Procedures in Paediatric population. In alignment with IDEAL (Idea, Development, Exploration, Assessment, Long-term study) Framework, this study will consist of 3 main phases to ensure proper procedure development while ensuring patients safety. Feasibility and safety will be assessed on an ongoing basis, and specifically after completion of the first 3 procedures, at a single site (Southampton/Lead), each conducted one week apart to allow the identification of unanticipated risks/adverse events. Once deemed safe, based on the results of the 3 cases enrolled in Phase I, 7 further cases would be completed, at the same site. Once the procedure is deemed safe according to safety data collected, the recruitment will proceed to full trial patient accrual, 140 additional cases from the 3 participating study sites.The study patient population is children and adolescents under the age of 18, which will be provided clinical care and follow-ups per standard of care and hospital's policy.

Conditions

Interventions

TypeNameDescription
DEVICEVersius Surgical SystemUrological minimal access surgery performed with Versius Surgical System

Timeline

Start date
2024-07-08
Primary completion
2027-01-01
Completion
2027-01-01
First posted
2024-08-06
Last updated
2024-10-15

Locations

3 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06539442. Inclusion in this directory is not an endorsement.